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Abstract 
Intense resistance exercise causes mechanical loading of skeletal muscle, followed by 
muscle adaptation. Chemotactic factors likely play an important role in these processes. 
Purpose: We investigated the time course of changes in the expression and tissue 
localization of several key chemotactic factors in skeletal muscle during the early phase of 
recovery following resistance exercise. Methods: Muscle biopsy samples were obtained 
from vastus lateralis of eight untrained men (220.5 yrs) before and 2, 4 and 24 h after 
three sets of leg press, squat and leg extension at 80% 1 RM. Results: Monocyte 
chemotactic protein-1 (95×), interleukin-8 (2,300×), IL-6 (317×), urokinase-type plasminogen 
activator (15×), vascular endothelial growth factor (2×) and fractalkine (2.5×) mRNA was 
significantly elevated 2 h post-exercise. Interleukin-8 (38×) and interleukin-6 (58×) protein 
was also significantly elevated 2 h post-exercise, while monocyte chemotactic protein-1 
protein was significantly elevated at 2 h (22×) and 4 h (21×) post-exercise. Monocyte 
chemotactic protein-1 and interleukin-8 were expressed by cells residing in the interstitial 
space between muscle fibers and, in some cases, were co-localized with CD68+ 
macrophages, PAX7+ satellite cells and blood vessels. However, the patterns of staining 
were inconclusive and not consistent. Conclusion: In conclusion, resistance exercise 
stimulated a marked increase in the mRNA and protein expression of various chemotactic 
factors in skeletal muscle. Myofibers were not the dominant source of these factors. These 
findings suggest that chemotactic factors regulate remodeling/adaptation of skeletal muscle 
during the early phase of recovery following resistance exercise. 
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RT-PCR: reverse transcription polymerase chain reaction 
TNF-: tumor necrosis factor- 
uPA: urokinase-type plasminogen activator 
VEGF: vascular endothelial growth factor 
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INTRODUCTION 
Skeletal muscle shows a remarkable capacity for rapid and extensive adaptation following 
mechanical loading. This adaptation involves complex and coordinated interactions between 
various cell types (e.g., macrophages and satellite cells) and proteins expressed and 
secreted by these cells (Charge and Rudnicki 2004). Proteins such as monocyte chemotactic 
protein (MCP)-1, tumor necrosis factor (TNF)-, interleukin (IL)-8, vascular endothelial 
growth factor (VEGF), macrophage-derived chemokine, leukemia inhibitory factor, 
fractalkine and urokinase-type plasminogen activator mediate muscle adaptation by acting 
as chemotactic factors for satellite cells, neutrophils and macrophages (Lu et al. 2011a; 
Peterson et al. 2006; Peterson and Pizza 2009; Bryer et al. 2008; Chazaud et al. 2003). In 
turn, these cells clear cellular debris and release factors that regulate satellite cell activity 
and myogenesis (Arnold et al. 2007; Tidball and Wehling-Henricks 2007; Lu et al. 2011b; 
Bryer et al. 2008; Chazaud et al. 2003). Some secreted proteins such as MCP-1, IL-6 and TNF-
 also directly stimulate myoblast proliferation and differentiation (Chen et al. 2007; Kurek 
et al. 1997; Serrano et al. 2008; Yahiaoui et al. 2008). 
 
The role of chemotactic factors as mediators of muscle adaptation is well established 
following severe and prolonged muscle injury and degeneration in mice (Bryer et al. 2008; 
Chen et al. 2005; Lu et al. 2011b; Lu et al. 2011a; Warren et al. 2002; Warren et al. 2004). By 
contrast, resistance exercise does not cause such severe muscle damage (Malm and Yu 
2012), yet it induces many of the hallmark characteristics of muscle regeneration and 
hypertrophy, including satellite cell activation, leucocyte infiltration and angiogenesis 
(Beaton et al. 2002; Moore et al. 2005; Psilander et al. 2003; Vella et al. 2012; Trenerry et al. 
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2007). Various studies have examined changes in the gene expression of various 
chemotactic factors, such as MCP-1, IL-8, TNF- and VEGF within skeletal muscle following 
resistance exercise (Buford et al. 2009; Louis et al. 2007; McKay et al. 2009; Nieman et al. 
2004; Hyldahl et al. 2011; Trenerry et al. 2007; Vella et al. 2012; Hubal et al. 2008). 
However, there were several important limitations in some of the studies.  
 
First, some of these studies only collected muscle samples at one time point after exercise 
(Buford et al. 2009; Nieman et al. 2004; Hyldahl et al. 2011; Hubal et al. 2008), which does 
not necessarily capture adaptation/remodeling of skeletal muscle during the early phases of 
recovery after exercise. Second, only a few of these studies examined the protein 
expression and cellular localization of chemotactic factors in skeletal muscle after exercise 
(McKay et al. 2009; Hyldahl et al. 2011; Hubal et al. 2008). Due to post-transcriptional 
modifications, cytokine/chemokine mRNA may not necessarily be translated to 
corresponding proteins in skeletal muscle after resistance exercise (Anderson 2008). 
Furthermore, measuring cytokine/chemokine mRNA expression in muscle homogenates to 
assess cytokine gene expression (Buford et al. 2009; Louis et al. 2007; Nieman et al. 2004; 
Trenerry et al. 2007; Vella et al. 2012) does not indicate which resident cell types in skeletal 
muscle secrete cytokines and chemokines after resistance exercise. 
 
Considering these analytical issues and the critical role of chemotactic factors as mediators 
of muscle adaptation, the aims of the present study were two-fold: (1) to explore the time 
course of changes in the expression of MCP-1, IL-6, IL-8, TNF-, VEGF, fractalkine and 
urokinase-type plasminogen activator following resistance exercise and (2) to assess the 
cellular localization of MCP-1 and IL-8 in cross-sections of muscle tissue. The findings from 
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this study demonstrate that mRNA and protein expression of many of these chemotactic 
factors increased in the first few hours after resistance exercise, and returned to normal 
after 24 h. Immunofluorescent staining for MCP-1 and IL-8 also increased after exercise, but 
it was unclear which cell types were the dominant sources of these chemokines in skeletal 
muscle after resistance exercise. 
 
 
MATERIALS AND METHODS 
 
Ethics statement 
Before participating in the study, the nature, purpose and risks of the study were explained 
to the subjects. They then provided informed written consent. All experimental procedures 
involved in this study adhered to the principles of the Declaration of Helsinki and were 
formally approved by the Deakin University Human Research Ethics Committee. 
 
Subjects 
Thirteen untrained, but recreationally active individuals volunteered to take part in this 
study. Eight males participated in the exercise component of this study (mean + SD age 22.0 
± 0.5 yrs, height 1.79 ± 0.05 m, body mass 83.3 ± 19.1 kg and BMI 24.1 ± 0.1 kg.m-2). The 
other individuals comprised a non-exercising control group (23.0 ± 0.9 yrs, 1.76 ± 0.05 m, 
74.0 ± 4.8 kg and 23.8 ± 2.0 kg.m-2).  Exclusion criteria included resistance training within the 
past six months, any medications, or a previous history of a diagnosed condition or illness 
that would present a health risk during strenuous resistance exercise. We also restricted this 
7 
 
study to males because of the well known effects of estrogen on muscle inflammation and 
regeneration (Kendall and Eston 2002), which was not the main focus of this study.  
 
Experimental design 
Each subject in the exercise group completed a familiarization session prior to the 
experimental protocol to learn how to perform each exercise, and to determine their 
individual 1 repetition maximum (1 RM). During the session, a 5 RM test was performed for 
each subject for the leg press, squat (assisted by the Smith machine) and leg extension. 1 
RM was then calculated using the Brzycki equation (1 RM=weight lifted (kg)/1.0278–[reps to 
fatigue x 0.0278]). The familiarization session took place at least 7 days prior to allow ample 
recovery time before the experimental trial commenced. 
 
For the 24 h preceding exercise, and the day of the trial, the subjects consumed a standard 
diet (20% fat, 14% protein and 66% carbohydrate) and abstained from alcohol, caffeine, 
tobacco and additional exercise. On the morning of the trial, subjects presented to the 
laboratory in a fasted state. Following 30 min of supine resting, a muscle sample was 
collected from the vastus lateralis under local anesthesia (Xylocaine 1%) by percutaneous 
needle biopsy technique modified to include suction. Excised muscle tissue from each 
biopsy was immediately frozen and stored in liquid nitrogen for later analysis. Subjects then 
completed a single bout of resistance exercise, specifically targeting muscles of the leg. 
Following 5 min of light cycling for warm-up, subjects completed two sets of eight to twelve 
repetitions of bilateral leg press, squat and leg extension at 80% 1-RM. This was followed by 
a third set to voluntary fatigue, also at 80% 1-RM. Subjects were allowed 1 min rest 
between exercises and 3 min rest between sets. The entire exercise protocol lasted 2025 
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min. This intensity of this exercise protocol was similar to other studies on resistance 
exercise (Buford et al. 2009; Louis et al. 2007; Vella et al. 2012), but lower than other studies 
involving purely eccentric exercise that caused severe muscle damage (McKay et al. 2009; 
Hubal et al. 2008). 
 
Additional muscle samples were collected at 2 h and 4 h after the exercise. Subjects were 
provided with their evening meal on the day preceding the trial as well as lunch and their 
evening meal for the days of the trial. The following morning, subjects again reported to the 
laboratory in a fasted state for the collection of a final muscle sample 24 h post-exercise. To 
minimize the potential for inflammation arising from the biopsy procedure itself, biopsies 
were collected from separate incisions in the same leg, at least 2 cm distal from previous 
biopsy sites. We collected venous blood samples before exercise, and again at 24 and 48 
hours after exercise. Blood samples were collected in tubes containing lithium heparin and 
centrifuged for 10 min at 2,500 rpm to separate the plasma. Plasma was stored in aliquots 
at 80°C prior to analysis. 
 
We included a non-exercising control group to examine whether the muscle biopsy 
procedure itself caused any inflammatory responses in skeletal muscle. Five individuals in 
the control group reported to the laboratory in a fasted state, having abstained from 
alcohol, caffeine, tobacco and additional exercise in the previous 24 h. Muscle biopsies were 
collected (as described above) at rest (0 h) and at 2 and 4 h following the initial muscle 
sampling. Between the collection of the biopsies, the control subjects rested with minimal 
movement. 
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RNA extraction and RT-PCR 
Total cellular RNA was extracted using a modification of the phenol/chloroform extraction 
and isopropanol precipitation protocol, using the TōTALLY RNA™ Kit (Ambion Inc., Austin, 
TX). RNA quality and concentration were determined using the Agilent 2100 Bioanalyzer 
(Agilent Technologies, Palo Alto, CA). First-strand cDNA was generated from 0.5 μg total 
RNA using the AMV RT kit (Promega, Madison, WI). RT-PCR was performed using the 
GenAmp 7500 sequence detection system (Applied Biosystems, Foster City, CA). PCR was 
performed in duplicate with reaction volumes of 20 l, containing SYBR Green 1 (Applied 
Biosystems), forward and reverse primers and cDNA template (diluted 1:20). Data were 
analyzed using a comparative critical threshold (Ct) method where the amount of target 
normalized to the amount of endogenous control relative to control value is given by 2-ΔΔCt 
(Applied Biosystems, Foster City, CA). GAPDH was selected as an endogenous control 
because expression of this gene was unchanged in response to the exercise intervention or 
sampling time (data not shown). Primers for MCP-1, IL-8, TNF-α, IL-6, macrophage-derived 
chemokine (MDC), VEGF, fractalkine (FKN), urokinase-type plasminogen activator (uPA) and 
myogenin were designed using Primer Express software package version 3.0 (Applied 
Biosystems) from gene sequences obtained from GenBank (see Table 1 for details). 
 
Multiplex analysis 
A bio-plex assay (Bio-Rad Labarotories, Hercules, CA) was used to analyze the protein 
expression of cytokines within skeletal muscle tissue. In the present study, kits were 
designed for the simultaneous analysis of IL-6, IL-8, MCP-1 and TNF-α. The assay was 
conducted following the manufacturer’s instructions (Bio-Rad Labarotories, Hercules, CA) 
and using reagents from the Cytokine reagent kit (Bio-Rad). Tissue samples (10 mg) were 
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homogenized in lysis buffer (20 mM Tris-HCl, 5 mM EDTA, 10 mM Na-pyrophosphate, 100 
mM NaF, 2 mM Na3VO4, 1% Igepal  CA-630, 10 g/ml Aprotinin, 10 g/ml Leupeptin, 3 mM 
Benzamidine, 1 mM phenylmethylsulfonyl fluoride (PMSF) using a hand-held homogenizer. 
The homogenate was rotated at 4°C for 1 h, centrifuged at 13,000 rpm at 4°C for 10 min, 
and the supernatant was collected. This supernatant was then diluted to 500 µg/ml. The 
supplied standards were diluted according to the manufacturer’s instructions for running 
the plate with the high sensitivity range (High PMT), which equated to 0.3–4,182pg/ml for 
IL-6, 0.1–2,353 pg/ml for IL-8, 0.2–2,718 pg/ml for MCP-1, and 0.6–9176 pg/ml for TNF-α. 
The plate was then read on the Bio-Plex Suspension Array System (V.5.0, Bio-Rad). All 
samples were run in triplicate, using the High PMT function. Average intra-assay CV% was as 
follows: IL-6: 10.6%, IL-8: 5.7%, MCP-1: 5.6% and TNF-α 12.1%. 
 
Immunohistochemistry 
A small section from each biopsy was dissected free of any connective tissue, blotted dry 
and then mounted in Tissue Tek (ProSciTech, Australia) and frozen in isopentane cooled in 
liquid nitrogen. Tissue sections (10 m) were fixed with 4% (w/v) paraformaldehyde in PBS 
for 10 min, permeated with 5% (v/v) Triton X-100 (TX100) for 5 min and blocked in 3% (w/v) 
bovine serum albumin in PBS overnight at 4˚C. Primary antibodies were diluted in blocking 
reagent as outlined in Table 2. All mouse primary antibodies were co-incubated with rabbit 
anti-Laminin (1:50 Sigma-Aldrich, St. Louis, MO), which was used to stain the sarcolemma. 
Tissue sections were incubated overnight at 4C with combinations of these primary 
antibodies. After five washes with PBS, sections were incubated at room temperature for 2 
h with appropriate secondary antibodies coupled to fluorophores (Alexa Fluor goat anti-
mouse 488 or donkey anti-rabbit 594 [Molecular Probes, Invitrogen, Australia]). Nuclei were 
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stained by incubating with the DNA binding dye, Bisbenzamide Hoechst 33285 (Sigma) for 
10 min. Following another series of washes, immuno-stained sections were visualized using 
an Olympus IX70 fluorescent microscope (Olympus, Australia), and digital images were 
collected using Spot RT slider camera and Magnifire Software (Olympus, Australia).  
 
Blood analysis 
We analyzed serum creatine kinase activity in pre- and post-exercise blood samples using an 
enzymatic assay (CK-NAC kit, CDT14010, Thermo-Fisher Scientific Clinical Diagnostics, 
Sydney, Australia) and an automated clinical analyser (Cobas Mira, Roche Diagnostics, 
Germany). We also analysed serum myoblobin concentration in these samples using an 
immunoassay (Roche Diagnostics, Germany) and an automated clinical analyzer (Cobas E411, 
Roche Diagnostics, Germany). The intra-assay coefficient of variation was 10.4% for creatine 
kinase and 1.7% for myoglobin. 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, San Diego, 
CA). Means were compared using one-way repeated measures analysis of variance (ANOVA) 
and any significant differences analyzed using a Newman-Keuls Multiple Comparison Test. 
Data are presented as mean±SEM. A probability level of <0.05 was adopted throughout to 
determine statistical significance. 
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RESULTS 
Compared with pre-exercise values, the mRNA abundance of MCP-1 (95) (Figure 1A), FKN 
(2.5) (Figure 1B), uPA (15) (Figure 1C), VEGF (2) (Figure 1D), IL-6 (317) (Figure 1E) and 
IL-8 (2,300) (Figure 1F) was significantly elevated at 2 h following exercise. uPA (11) and 
VEGF (2) mRNA was also significantly elevated beyond 2 h post-exercise. TNF-α mRNA did 
not change significantly following exercise (Figure 1G), while MDC mRNA expression was not 
detectable at any time point (data not shown). Our group has previously reported no 
changes in mRNA expression of these chemotactic factors as a result of the biopsy 
procedure itself (Vella et al. 2012). 
 
The bio-plex suspension assay system was used to assess the protein content of MCP-1, IL-8, 
IL-6 and TNF-α within muscle in both the exercise and non-exercising control groups. 
Following exercise,  the expression of MCP-1 (Figure 2A), IL-6 (Figure 2B) and IL-8 (Figure 2C) 
protein followed a very similar pattern to the mRNA expression, with the largest increase 
evident 2 h following exercise (MCP-1 22, IL-6 38 and IL-8 58). Although all of these 
factors remained elevated at later time points, only MCP-1 expression at 4 h post-exercise 
was significantly greater than pre-exercise values. TNF-α expression was below the range of 
the standards at each time point. Data from the non-exercising control group indicated no 
significant changes in the protein expression of MCP-1, IL-6 or IL-8 in response to the muscle 
biopsy procedure itself (Figure 2). 
 
At rest, both IL-8 (Figure 3A) and MCP-1 (Figure 3C) were not visible in skeletal muscle 
sections. Following exercise, however, staining for both IL-8 (Figure 3B) and MCP-1 (Figure 
3D) was clearly visible 2 h after exercise. MCP-1 (Figure 4A) and IL-8 (Figure 4B) was 
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localized within the endomysium between the muscle fibres and not within the muscle 
fibers themselves. To investigate which cells within the endomysium were associated with 
MCP-1 and IL-8 expression, serial sections of muscle tissue were stained, firstly, with MCP-1 
and IL-8, and then with antibodies for CD68 for macrophages, PAX7 for satellite cells and 
Collagen IV for blood vessels.  Within the subject cohort, we found several examples of 
MCP-1 and IL-8 co-staining with or in close proximity to macrophages (Figure 5) and small 
blood vessels (Figures 6 and 7), and of MCP-1 co-staining with satellite cells (Figure 6). 
However, the staining was not conclusive or consistent, and did not account for the 
widespread staining and large increase in the protein abundance of MCP-1 and IL-8 after 
following exercise.  IL-8 staining also appeared turquoise in many of the images, suggesting 
that IL-8 (shown in green) may be predominantly expressed by the nuclei of interstitial cells 
(shown in blue) (Figure 4). Large blood vessels were also evident in some sections and 
showed strong expression of MCP-1 (Figure 8). 
 
There were no significant changes in plasma creatine kinase activity (p=0.36) and plasma 
myoglobin concentration (p=0.56) after exercise (Figures 9A and 9B). 
 
 
DISCUSSION 
In this study, we have profiled changes in the gene and protein expression of various 
chemotactic factors in skeletal muscle at several time points during the early phases of 
recovery from resistance exercise. We have also demonstrated that MCP-1 and IL-8 
expression was not restricted to mature myofibers after resistance exercise. This study 
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highlights the complex interactions between various cell types and secreted proteins in the 
skeletal muscle microenvironment during early adaptation of skeletal muscle after exercise. 
 
Some exercise studies have only investigated changes in the gene expression of MCP-1, IL-6 
IL-8 and VEGF at a single time point after resistance exercise: immediately (Nieman et al. 
2004), 3 h (Hyldahl et al. 2011; Buford et al. 2009) or 6 h (Hubal et al. 2008) after exercise. 
We present new evidence that in addition to major chemotactic factors such as MCP-1 and 
IL-8, the gene expression of urokinase-type plasminogen activator and fractalkine also 
increased after exercise. Specifically, urokinase-type plasminogen activator and fractalkine 
was elevated at 2 h after exercise, while urokinase-type plasminogen activator mRNA 
expression remained elevated at 4 h post-exercise. Urokinase-type plasminogen activator is 
a chemoattractant for monocytes (Chazaud et al. 2003), which accounts for its role in 
muscle regeneration (Bryer et al. 2008). Fractalkine also likely promotes muscle adaptation 
after exercise by attracting monocytes (Chazaud et al. 2003) and stimulating angiogenesis 
(Volin et al. 2001). In contrast with muscle-damaging eccentric exercise, we propose that 
the increased gene expression of these chemokines after intense resistance exercise likely 
reflects their role in muscle adaptation/remodeling, rather than muscle repair. This notion is 
supported by our finding exercise did not cause any substantial muscle damage, as indicated 
by the lack of any significant changes in plasma creatine kinase activity and plasma 
myoglobin concentration at 24 and 48 h after exercise (see Figure 9). 
 
We discovered for the first time that in addition to IL-8 and MCP-1 mRNA, the protein 
abundance of these chemokines also increased markedly after resistance exercise. IL-8 
mRNA and protein expression peaked after 2 h. MCP-1 mRNA expression also peaked after 2 
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h, while MCP-1 protein expression remained elevated 4 h after exercise. The importance of 
MCP-1 and its receptor CCR2 in muscle adaptation is well established (Lu et al. 2011b; 
Shireman et al. 2007; Warren et al. 2005; Warren et al. 2004; Yahiaoui et al. 2008). One of 
the key mechanisms by which MCP-1/CCR2 regulate muscle adaptation is by recruiting 
monocytes to the site of muscle injury, where these cells are converted to macrophages 
(Chazaud et al. 2003; Lu et al. 2011b). MCP-1 may also assist muscle adaptation by 
stimulating the proliferation of myoblasts (Yahiaoui et al. 2008), vascular smooth muscle 
cells (Selzman et al. 2002) and endothelial cells (Weber et al. 1999). By contrast, the role of 
IL-8 in muscle adaptation is not so well defined. IL-8 may promote muscle adaptation by 
attracting neutrophils (Peterson and Pizza 2009) and upregulating expression of VEGF 
receptors (Petreaca et al. 2007).  
 
The large increase in the protein expression of MCP-1 and IL-8 (as measured using the bio-
plex assay) strongly suggests that there was also a substantial increase in the number 
and/or activity of cells secreting these chemokines in skeletal muscle. Relatively few studies 
have attempted to identify the cells types that secrete cytokines and chemokines in skeletal 
muscle after resistance exercise (Hubal et al. 2008; McKay et al. 2009). Muscle cells secrete 
MCP-1 and IL-8 in vitro in response to cyclic strain (Nedachi et al. 2009; Peterson and Pizza 
2009) and stimulation with other cytokines (Sugiura et al. 2000; De Rossi et al. 2000; Marino 
et al. 2008). However, in healthy individuals, and patients with inflammatory myopathies, 
MCP-1 and IL-8 are not expressed within myofibers. Rather, they are expressed within blood 
vessels and regions of inflammation (De Paepe et al. 2007). It was therefore not surprising 
that we could not detect MCP-1 and IL-8 within myofibers before exercise. After exercise, 
there was little change in MCP-1 and IL-8 staining within myofibers. Instead, these factors 
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were expressed within the endomysium between the myofibers. We attempted to identify 
the cells within this region that were secreting MCP-1 and IL-8 after exercise by staining 
tissue sections with CD68 for macrophages, PAX7 for satellite cells and collagen IV for blood 
vessels. There were no consistent patterns of staining associated with these cell types. In a 
few samples, MCP-1 staining was co-localized with satellite cells (Figure 5). By contrast, in 
other samples MCP-1 and IL-8 staining was co-localized with macrophages and/or within 
large blood vessels (Figures 4, 5 and 6).  
 
These findings highlight two important issues. First, muscle cells themselves do not appear 
to be a major source of MCP-1 and IL-8 after resistance exercise. Second, despite the 
marked increase in the gross protein abundance of MCP-1 and IL-8 in skeletal muscle, the 
patterns of tissue staining for the chemokines show substantial variation. Further work 
using more advanced imaging technology (e.g., confocal microscopy) is warranted to 
investigate which types of cells secrete chemotactic factors in skeletal muscle following 
exercise, and whether this secretion is regulated in an autocrine or paracrine manner. 
 
Consistent with the changes in MCP-1 and IL-8 expression, we identified that expression of 
IL-6 mRNA and protein also increased dramatically in skeletal muscle after resistance 
exercise. IL-6 regulates muscle adaptation after exercise by stimulating satellite proliferation 
(Toth et al. 2011). The lack of any change in TNF- expression following exercise in the 
present study was somewhat surprising. TNF- is a chemotactic agent in vitro (Peterson et 
al. 2006), and plays an important role in muscle regeneration following myotoxin injury 
(Chen et al. 2005) and freeze injury (Warren et al. 2002). Other research has reported an 
increase in TNF- mRNA expression in skeletal muscle after resistance exercise (Buford et al. 
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2009; Louis et al. 2007; Nieman et al. 2004). Possible reasons for the disparity between our 
findings and other studies may include differences in the timing of muscle biopsies, training 
status of the subjects and/or methods of molecular analysis. Only a few studies have 
detected TNF- protein expression in human skeletal muscle using enzyme-linked 
immunoassay (Barreiro et al. 2008; Greiwe et al. 2001), Western blotting (Plomgaard et al. 
2007; Kim et al. 2011) and immunohistochemistry (Plomgaard et al. 2007; Plomgaard et al. 
2005). The bio-plex assay that we used in the current study may not have been sensitive 
enough to detect TNF- protein. Plomgaard et al (Plomgaard et al. 2005) reported that only 
type II muscle fibers express TNF- protein. In the present study, we collected muscle 
samples from vastus lateralis, which is comprised of equal proportions of type I and II fibers 
(Plomgaard et al. 2005). TNF- protein expression may therefore be greater after exercise in 
muscle comprised of a higher proportion of type II fibers. 
 
In conclusion, this study demonstrates that the early phase of recovery from intense 
resistance exercise is characterized by a large increase in the gene and protein expression of 
several important chemotactic factors. Although somewhat inconclusive, the 
immunohistochemistry analysis in this study is suggestive of complex communication and 
secretory actions between myofibers, macrophages, satellite cells and other stromal cells, 
and the major sources of these factors within skeletal muscle are cells residing within the 
endomysium. Importantly, the marked increased in the protein expression of MCP-1, IL-8 
and IL-6 in the first few hours after resistance exercise follows a similar time course to 
myogenesis and protein synthesis in skeletal muscle. The chemotactic function of 
chemokines is an essential aspect of muscle adaptation to mechanical loading. However, the 
current data indicate that chemokine expression in skeletal muscle after exercise peaks 
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before monocytes typically begin to invade muscle fibers. More research is therefore 
required to determine the sequence of events leading to chemokine production in skeletal 
muscle, in addition to the targets and functions of chemokines in muscle fiber adaptation 
following exercise.  
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Figure Legends 
Figure 1 – The effect of a single bout of resistance exercise on skeletal muscle mRNA 
expression of MCP-1 (A), fractalkine (B), urokinase-type plasminogen activator (C), VEGF (D), 
IL-6 (E)  IL-8 (F) and TNF-α (G). Values are arbitrary units normalized to the expression levels 
of the housekeeping gene GAPDH representing the mean ± SEM for eight individuals. * 
Significantly different from resting levels (p<0.05). 
Figure 2 – Protein abundance of MCP-1, IL-8 and IL-6 within skeletal muscle homogenate in 
response to resistance exercise and in a biopsy-only control group. Multiplex analysis using 
a Bio-plex assay was used to quantify expression of MCP-1 (A), IL-8 (B), IL-6 (C) in biopsy-
only controls (white bars) and in response to resistance exercise (black bars). Values are 
mean ± SEM protein abundance normalized to total protein loaded per well for eight 
individuals. TNF-α was below the range of measurement at all time points. * Significantly 
different from resting levels (p<0.05). 
 
Figure 3 – IL-8 (A,B) and MCP-1 (C,D) localization within skeletal muscle before and 2 h after 
a single bout of resistance exercise from a representative subject. At rest, neither IL-8 (A, 
green) nor MCP-1 (C, green) staining was visible.  Following exercise, widespread staining 
for both in IL-8 (B, green) and MCP-1 (D, green) was visible. Sections were also double 
stained with an antibody against laminin (red, sarcolemma) and bisbenzamide (blue, nuclei). 
Scale bar = 100 µm. 
 
Figure 4 – High magnification (40x) images of MCP-1 (A) and IL-8 (B) localization within 
skeletal muscle before and 2 h after a single bout of resistance exercise from a 
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representative subject. Images show expression of both MCP-1 and IL-8 was confined to 
cells outside the sarcolemma and within the endomysium. Sections were also double 
stained with an antibody against laminin (red, sarcolemma) and bisbenzamide (blue, nuclei). 
Scale bar = 100 µm. 
 
Figure 5 – Representative serial sections indicating co-localization of MCP-1 and IL-8 with 
macrophages (CD68) 2 h following resistance exercise. Sections were stained with either 
anti-mouse CD68 (A), MCP-1 (B) or IL-8 (C), all of which appear green. Sections were also 
double stained with an antibody against laminin (red, sarcolemma) and bisbenzamide (blue, 
nuclei). Scale bar = 100 µm. 
 
Figure 6 - Representative serial sections indicating co-localization of MCP-1 with satellite 
cells (PAX7) and showing MCP-1 in close proximity to blood vessels (Collagen IV) 2 h 
following resistance exercise. Sections were stained with either anti-mouse MCP-1 (A), PAX7 
(B) or Collagen IV (C), all of which appear green. Sections were also double stained with an 
antibody against laminin (red, sarcolemma) and bisbenzamide (blue, nuclei). Scale bar = 100 
µm. 
 
Figure 7 - Representative serial sections indicating co-localization of IL-8 with blood vessels 
(Collagen IV) 2 h following resistance exercise. Sections were stained with either anti-mouse 
IL-8 (A) or Collagen IV (B), both of which appear green. Sections were also double stained 
with an antibody against laminin (red, sarcolemma) and bisbenzamide (blue, nuclei). Scale 
bar = 100 µm. 
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Figure 8 – Large blood vessels within skeletal muscle cross sections expressed MCP-1 
(green) 2h (A) and 24h (B) following resistance exercise.  Sections were also double stained 
with an antibody against laminin (red, sarcolemma) and bisbenzamide (blue, nuclei). Scale 
bar = 100 µm. 
 
Figure 9 – Plasma creatine kinase (CK) activity (A) and myoglobin concentration (B). Values 
are mean ± SEM.  
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Tables 
 
Table 1 – List of Primers used for RT-PCR. 
Gene 
GenBank 
Accession no. 
Forward (5’ – 3’) Reverse (5’ – 3’) 
MCP-1 NM_002982 CGCCTCCAGCATGAAAGTCT GGAATGAAGGTGGCTGCTATG 
MDC NM_002990.3 GCGCGTGGTGAAACACTTC ACTCTGGGATCGGCACAGAT 
VEGF AYO41581 GCGCAAGAAATCCCGGTATA GCTTTCTCCGCTCTGAGCAA 
FKN NM_002996.3 CGAAAGATGGCAGGAGAGATG GGGCACCAGGACATATGAATTAC 
uPA NM_002658.3 GGAAAACCTCATCCTACACAAGGA GGATCTTCAGCAAGGCAATGTC 
IL-8 NM_000584 CTGGCCGTGGCTCTCTTG TTAGCACTCCTTGGCAAAACTG 
TNF-α NM_000594 GGAGAAGGGTGACCGACTCA TGCCCAGACTCGGCAAAG 
IL-6 NM_000600 GTGACATCCTCGACGGCATCT GTGCCTCTTTGCTGCTTTCAC 
GAPDH NM_002046 CATCCATGACAACTTTGGTATCGT CAGTCTTCTGGGTGGCAGTGA 
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Table 2: Details of primary antibodies used for immunofluorescence. 
Antigen Antibody Clone Dilution Source 
MCP-1 Mouse monoclonal IgG 5J 1:20 Santa Cruz (Santa Cruz, CA) 
IL-8 Mouse monoclonal IgG NYR-HIL8 1:40 Santa Cruz 
CD68 Mouse monoclonal IgG E-11 1:100 Santa Cruz 
PAX7 Mouse monoclonal IgG PAX7 1:20 
Developmental Studies Hybridoma 
Bank (Iowa city, IA) 
Collagen IV Mouse monoclonal IgG M3F7 1:100 
Developmental Studies Hybridoma 
Bank 
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